14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
OHI vs AHR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
OHI Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)
OHI Overall Winner
6-Pillar Tally: OHI 5 – 1 AHR
Matrix Metrics: OHI 8 – 2 AHR
As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over American Healthcare REIT, Inc. (AHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas AHR carries 35.9/100 (SELL) at $57.87 (58.4x Forward P/E, 6.8% operating margin).
Growth vs. Quality Trade-Off: OHI earns the overall head-to-head edge with a stronger Unified Composite Score (50.5/100 HOLD vs. AHR 35.9/100 SELL) and -0.04β · 29% Vol risk profile, whereas AHR leads top-line expansion (+29.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile AHR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 64.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OHI vs AHR. Trailing 12-month operating profitability (OHI 62.6% vs AHR 6.8%) and valuation multiples (OHI 22.6x vs AHR 58.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the REIT - Healthcare Facilities value chain with $13.6B market capitalization and 6.8% operating margin.
OpEx & R&D Reinvestment13.5% of Rev ($361M)
90D Engineering Disclosures0 Published
Investor FAQ OHI vs AHR Key Questions & Quantitative Answers
As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over American Healthcare REIT, Inc. (AHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas AHR carries 35.9/100 (SELL) at $57.87 (58.4x Forward P/E, 6.8% operating margin). Growth vs. Quality Trade-Off: OHI earns the overall head-to-head edge with a stronger Unified Composite Score (50.5/100 HOLD vs. AHR 35.9/100 SELL) and -0.04β · 29% Vol risk profile, whereas AHR leads top-line expansion (+29.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile AHR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 64.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AHR leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with AHR at +29.4% YoY revenue growth and -57.6% YoY earnings growth on $2.67B TTM revenue (20.3% gross margin, 6.8% operating margin). On trailing 12-month operating scale, OHI generates $1.26B in USD-normalized revenue versus $2.67B for AHR. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 13.5% of Rev ($361M) (0 disclosures) for AHR.
OHI screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas AHR trades at 58.4x Forward P/E, 119.7x Trailing P/E, N/M PEG, and 5.1x EV/Revenue (18.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus AHR (2.3% ROE) capital efficiency.
In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, AHR carries 31.1% implied volatility (27th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.03β · 32% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.